True Leaf Achieves Another Milestone Toward a Medical Marijuana License

- July 21st, 2015

True Leaf Medicine International Ltd. (CSE:MJ) announced that it has received “additional enhanced screening” notice from Health Canada, bringing it one step closer to becoming a licensed producer under the Marihuana for Medical Purposes Regulations (MMPR).

True Leaf Medicine International Ltd. (CSE:MJ) announced that it has received “additional enhanced screening” notice from Health Canada, bringing it one step closer to becoming a licensed producer under the Marihuana for Medical Purposes Regulations (MMPR).
As quoted in the press release:

In a July 16, 2015 letter, Health Canada acknowledged eight previous ‘requests for information’ from May 27, 2014 to the most recent on March 5, 2015 and sought additional clarification regarding production and storage of medical cannabis at True Leaf’s Lumby, BC facility.
As of March 15, 2015, there were 25 licensed applicants in Canada. True Leaf’s application is among the 324 remaining of the total of 1284 applications received. A total of 934 applications have been rejected or withdrawn.
Health Canada set an August 3, 2015 deadline for answers to its questions.
True Leaf CEO Darcy Bomford indicated that True Leaf will continue to comply with Health Canada requests for supplementary information, as it has since its original license application submission on July 30, 2013 which received an application number 10-MM0048 and a ‘ready-to-build’ approval on January 28, 2014. A second pending application number 10-MM0498 has been assigned for the Lumby, BC location.

Darcy Bomford, CEO of True Leaf, commented:

We’re optimistic that the additional enhanced screening means the government is close to the next phase. We’re doing everything we can to demonstrate that we’re serious about respecting the legal licensing route.

Click here to read the full True Leaf Medicine International Ltd. (CSE:MJ) press release.

Get the latest Cannabis Investing stock information

Leave a Reply